Compare BLDP & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLDP | RXRX |
|---|---|---|
| Founded | 1979 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2009 | 2021 |
| Metric | BLDP | RXRX |
|---|---|---|
| Price | $5.19 | $3.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $2.34 | ★ $7.50 |
| AVG Volume (30 Days) | 12.7M | ★ 18.3M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $14.53 | $12.11 |
| Revenue Next Year | $18.02 | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $1.51 | $2.77 |
| 52 Week High | $6.57 | $7.18 |
| Indicator | BLDP | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.81 | 48.60 |
| Support Level | $2.31 | $2.85 |
| Resistance Level | N/A | $3.99 |
| Average True Range (ATR) | 0.56 | 0.29 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 46.95 | 40.55 |
Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from United States followed by Poland, Canada, and other countries.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.